fbpx

EMERGERS

Equity Research of
Nordic Growth Companies

Home

Etikett: Simris Alg

Interview | SIMRIS GROUP: CEO Julian Read about venture into ADCs and CDMO deal with Lonza Ltd

2023-03-08• Okategoriserade

Interview with SIMRIS GROUP CEO Julian Read about the venture into ADCs, the CDMO deal with Lonza Ltd and where he expects that Simris...

Read More →

SIMRIS GROUP: Lonza partnership brings ADC platform deals closer

2023-03-06• Analys, Research

The strategic partnership with Lonza puts Simris in a stronger position going forward as it both validates Simris IP in the high value...

Read More →

SIMRIS ALG: Transforming to build an integrated multi-vertical microalgae and cyanobacteria company  

2023-02-20• Analys, Research

Simris’ expanded objective to leverage the acquisition of Cyano Biotech in Q3’22, enter the high-value biopharma space and build a...

Read More →

SIMRIS ALG: Ready to execute on a three-pronged roadmap to capture the most high-value opportunities

2022-11-11• Analys, Research

Following the successful acquisition of Cyano Biotech GmbH in Q3, Simris is now moving forward with a three-pronged approach to value...

Read More →

SIMRIS ALG: Cyano deal jumpstarts venture into Biopharma | See interview with CEO Julian Read

2022-09-07• Analys

With the successful completion of the acquisition of Berlin-based Cyano Biotech GmbH, Simris Alg is now set to accelerate their entry into...

Read More →

SIMRIS ALG: Accelerating entry into high-value BioPharma with acquisition of Cyano Biotech

2022-08-18• Analys

In line with their strategic plan to move into the highest margin application areas, Simris Alg announced an LOI to acquire Cyano Biotech...

Read More →

SIMRIS ALG: Targeting biopharma to exploit highest value verticals in the microalgae and cyanobacteria space

2022-08-05• Analys

With the new CEO in place, Simris has now set course to pursue the most high value application area for microalgae, the biopharma sector in...

Read More →

Simris Alg fueling up for incoming CEO to build on accelerating momentum

2022-04-25• Analys

On the back of 7.5 MSEK in orders in the last eight months and new CEO Julian Read taking the helm on May 16th, Simris is set to strengthen...

Read More →

Fourth fucoxanthin order confirms commercial turnaround and sets Simris up for revaluation in 2022

2022-03-01• Okategoriserade

With four orders with a total value of 7.5 MSEK in the last eight months, of which two booked in the first two months of 2022, it is now...

Read More →

M&A-aktivitet på växande mikroalgsmarknad indikerar ”tenbagger”-potential för Simris

2021-09-14• Analysartiklar

Det senaste decenniet har intresset för mikroalger satt nya rekord. Med en vertikalt integrerad plattform för mikroalger och en ny VD på...

Read More →

Actionable Investment Research | Sectors & Themes | Shorts and Frauds

Widmark Research 

CONTACT

Johan Widmark

Mail: johan@emergers.se
Tel: +46739196641

Östermalmsgatan 26A
114 26 Stockholm, Sweden

For new research on growth stocks, sign up to our newsletter